Orthofix Medical Inc.'s (NASDAQ:OFIX) value has fallen 15% in the last week, but insiders who sold US$879k worth of stock over the last year have had less success. Insiders might have been better off holding onto their shares, given that the average selling price of US$13.38 is still below the current share price.
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
The President, Massimo Calafiore, made the biggest insider sale in the last 12 months. That single transaction was for US$301k worth of shares at a price of US$15.82 each. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. The silver lining is that this sell-down took place above the latest price (US$6.07). So it may not tell us anything about how insiders feel about the current share price.
Happily, we note that in the last year insiders paid US$124k for 10.00k shares. On the other hand they divested 65.72k shares, for US$879k. All up, insiders sold more shares in Orthofix Medical than they bought, over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
Check out our latest analysis for Orthofix Medical
If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).
In the last three months company President of Global Biologics & Limb Reconstruction Patrick Fisher divested US$1.4k worth of stock. That is not a lot. Ultimately the overall selling isn't enough to tell us much.
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our data suggests Orthofix Medical insiders own 0.8% of the company, worth about US$2.1m. We prefer to see high levels of insider ownership.
We did not see any insider buying in the last three months, but we did see selling. However, the sales are not big enough to concern us at all. Recent insider selling makes us a little nervous, in light of the broader picture of Orthofix Medical insider transactions. And we're not picking up on high enough insider ownership to give us any comfort. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. At Simply Wall St, we found 1 warning sign for Orthofix Medical that deserve your attention before buying any shares.
But note: Orthofix Medical may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.